MATINAS BIOPHARMA HOLDINGS INC (MTNB)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$0.18+0.55%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · MTNB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | — | — | — | 1.1 | 3.2 | 0.0 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.2 | — |
| Total Revenues | — | — | — | — | — | — | — | — | 0.1 | 0.1 | 0.0 | 0.2 | — |
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | — | 0.1 | 11.4 | 14.5 | 16.7 | 14.6 | 14.4 | 11.2 | 6.8 | 9.0 | 3.9 | 5.3 | 5.2 |
| Operating Income | (6.7) | (7.0) | (24.6) | (23.8) | (24.6) | (24.7) | (24.2) | (18.9) | (14.6) | (16.5) | (8.3) | (9.9) | (10.5) |
| Earnings from Continuing Operations | |||||||||||||
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | 0.5 | 0.1 | 0.0 | (0.0) | 0.0 | (0.0) |
| EBT, Incl. Unusual Items | — | (10.3) | (24.3) | (22.9) | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | (0.1) | — | — | — | — | 0.5 | 0.5 | 0.4 | — | — | 0.3 |
| Net Income | |||||||||||||
| Net Income | (6.7) | (10.3) | (24.3) | (22.9) | (21.0) | (23.3) | (22.4) | (17.4) | (14.1) | (15.5) | (7.6) | (9.1) | (10.2) |
| Per Share | |||||||||||||
| Basic EPS | (1.04) | (2.00) | (4.98) | (5.28) | (0.10) | (0.11) | — | — | — | — | — | — | — |
| Diluted EPS | (1.04) | (2.00) | (4.98) | (5.28) | (0.10) | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 6.4 | 5.5 | 4.9 | 4.3 | 216.8 | 210.2 | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 6.4 | 5.5 | 4.9 | 4.3 | 216.8 | — | — | — | — | — | — | — | — |
| Supplemental | |||||||||||||
| EBITDA | — | (6.9) | (24.2) | (23.4) | (24.3) | (24.5) | (24.0) | (18.7) | (14.4) | (16.4) | (8.2) | (9.9) | — |
| EBIT | (6.7) | (7.0) | (24.6) | (23.8) | (24.6) | (24.7) | (24.2) | (18.9) | (14.6) | (16.5) | (8.3) | (9.9) | (10.5) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.